(Q36040696)

11 August 2017

1 reference

title

Topoisomerases in the treatment of metastatic or recurrent squamous carcinoma of the head and neck (English)

1 reference

11 August 2017

head and neck carcinoma

1 reference

Barbara A Murphy

1

1 reference

PubMed ID

15709886

11 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Expert Opinion on Pharmacotherapy

11 August 2017

1 reference

11 August 2017

6

1 reference

11 August 2017

1

1 reference

11 August 2017

85-92

1 reference

Chemotherapy in the management of squamous-cell carcinoma of the head and neck

11 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.85

Organ preservation trials for laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.85

Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.85

RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.85

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.85

Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.85

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.85

Topoisomerase I inhibitors: review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.85

Lack of efficacy of topotecan in the treatment of metastatic or recurrent squamous carcinoma of the head and neck: an Eastern Cooperative Oncology Group Trial (E3393).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.85

Phase II study of docetaxel and topotecan combination chemotherapy in patients with advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.85

Effects of CPT-11 in combination with other anti-cancer agents in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.85

In vitro schedule-dependent interaction between paclitaxel and SN-38 (the active metabolite of irinotecan) in human carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.85

Radiation lethality enhancement with 9-aminocamptothecin: comparison to other topoisomerase I inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.85

Inhibition of radiation-induced neoplastic transformation by beta-lapachone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.85

Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.85

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.85

21 January 2018

Identifiers

DOI

10.1517/14656566.6.1.85

1 reference

11 August 2017

1 reference

PubMed ID

15709886